Application 210804
- Type
- ANDA
- Sponsor
- MSN PHARMACEUTICALS INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | AFATINIB | AFATINIB | TABLET;ORAL | 20MG | No | No |
| 002 | AFATINIB | AFATINIB | TABLET;ORAL | 30MG | No | No |
| 003 | AFATINIB | AFATINIB | TABLET;ORAL | 40MG | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Afatinib | AFATINIB | Camber Pharmaceuticals, Inc. | ec5b9e00-3eab-4dbd-9bb3-75865b1af485 | 2026-09-03 | Warnings, Adverse reactions | Afatinib AFATINIB |
| Gilotrif | AFATINIB | Boehringer Ingelheim Pharmaceuticals, Inc. | fd638e5e-8032-e7ca-0179-95e96ab5d387 | 2025-11-13 | Warnings, Adverse reactions | AFATINIB |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Documents#
| Document | Submission type | Date |
|---|---|---|
| 73763 | ORIG | 2026-03-19 |